The Role
The Senior Director will report to the VP of ERAD Operations and be responsible, as part of the External R&D and Partnering team (ERAD), for helping ensure our portfolio companies have access to the absolute best vendors to support them in delivering on their seed milestones. In this role, you will be a part of the connective tissue between our CSO pods that act as co-pilots to our portfolio companies and our external network of vendor partners and CROs. Internally, you will ensure our Co-Piloting team and portfolio companies have a white glove working relationship with the top strategic vendors. Externally, you will help build a best in class network of vendors who we treat as long term partners, not transactional order takers. Our ideal candidate is excited by the breadth (majority of modalities/indications), scale, and stage (primarily discovery) of our portfolio.
Responsibilities
Requirements and Qualifications
The People:
In order for Curie.Bio to achieve its mission, we need the best people. Companies are nothing more than a group of people working together on a shared objective. Great companies are when those individuals come together to form something larger than the sum of its parts. By design, Curie.Bio is a flat organization to better serve the Founders and portfolio companies.
The Company:
Curie.Bio is a founder-focused, early-stage venture firm combined with an industry-grade therapeutics accelerator focused on one thing: helping entrepreneurial founders launch viable therapeutics companies. Curie.Bio does this by giving founders access to a team of the world’s best drug hunters and drug makers, seed capital, and best-of-breed services - everything a founder needs to get from concept to a compelling dataset that enables an awesome Series A financing and more. In a nutshell, we want founders focused on their area of expertise and creativity, while we help make the rest happen smoothly.
We manage two funds: the Seed Fund and the Breakout Fund. The Seed Fund focuses on advancing therapies through preclinical milestones, such as achieving in vivo proof-of-concept or selecting a development candidate. The Breakout Fund focuses on advancing medicines through clinical trials to generate impactful human activity data.
As an employee joining us on this mission, you will see first hand what it takes to successfully bring a company from concept at the seed stage to compelling wet-lab derived POC data with an industry-grade progressible drug (candidate) that enables a Series A financing and beyond. You will work alongside the world’s best drug hunters and industry veterans whose experience spans all facets of drug discovery and preclinical drug development - from disease biology to medicinal chemistry, to recruiting, to business development, and more.
Please find our Privacy Policy here.
Understand the required skills and qualifications, anticipate the questions you may be asked, and study well-prepared answers using our sample responses.
Senior Director Q&A's